Clinical trial
Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis…
NCT00306228 · GRACIA Group, Other · Completed
Key facts
| NCT number | NCT00306228 |
|---|---|
| Title | Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty |
| Official title | A Randomised Trial to Evaluate the Role of Paclitaxel Eluting Stent and Tirofiban to Improve the Results of Facilitated PCI in the Treatment of Acute ST- Segment Elevation Myocardial Infarction |
| Acronym | GRACIA3 |
| Lead sponsor | GRACIA Group, Other |
| Collaborators | Spanish Ministry of Health. Ministry of Science and Innovation, Spain |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Procedure |
| Interventions | Postfibrinolysis percutaneous coronary intervention |
| Enrollment | 436 |
| Start date | Oct 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Mar 23, 2006 |
| Last update posted | Sep 28, 2009 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: